Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-11

Clinical Trial Update: CyberSenga: Internet-based HIV Prevention in Uganda [Phase 1]

View source ↗

Summary

The Phase 1 trial of CyberSenga, an internet-based HIV prevention program in Uganda, has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Center for Innovative Public Health Research | Conditions: Sexual Abstinence, Condom Use | Phase 1 | Status: COMPLETED | Results posted: 2016-08-11